We compared Cell C’s company-saving deals — and it looks worse-off now than in 2017
Performing a like-for-like comparison of Cell C's balance sheet after its two recapitalisations in 2017 and 2022 raises major concerns.

This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.